Principal Financial Group Inc I Bio, Inc. Transaction History

Principal Financial Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.23 - $0.46 $10,011 - $20,022	-43,528 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$0.3 - $0.61 $417 - $847	-1,390 Reduced 3.09%	43,528 $19,000
Q4 2021 Feb 09, 2022	SELL	$0.55 - $1.04 $8,821 - $16,680	-16,039 Reduced 26.31%	44,918 $24,000
Q3 2021 Nov 09, 2021	SELL	$1.06 - $1.52 $14,676 - $21,045	-13,846 Reduced 18.51%	60,957 $64,000
Q2 2021 Aug 10, 2021	SELL	$1.22 - $1.65 $1.26 Million - $1.7 Million	-1,031,215 Reduced 93.24%	74,803 $112,000
Q1 2021 May 10, 2021	BUY	$1.18 - $2.62 $97,577 - $216,655	82,693 Added 8.08%	1,106,018 $1.7 Million
Q4 2020 Feb 08, 2021	BUY	$1.05 - $2.24 $1.07 Million - $2.29 Million	1,023,325 New	1,023,325 $1.08 Million

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.